Physician profile
Patrick Killian
NPI 1982663324
$2,651.14
in general payments reported to CMS, 2019-2025
20 companies · $550 in 2025
The $550 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.80 · 2020: $33.62 · 2021: $83.76 · 2022: $397 · 2023: $555 · 2024: $996 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,100.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $485.32 | 2019-2025 | |
| Lilly USA, LLC | $450.26 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Regeneron Healthcare Solutions, INC. | $279.15 | 2022-2025 | Dupixent, Libtayo |
| Dermavant Sciences, INC. | $258.44 | 2023-2024 | Vtama |
| Janssen Biotech, INC. | $181.10 | 2022-2025 | Tremfya, Simponi, Simponi Aria |
| Sun Pharmaceutical Industries INC. | $151.87 | 2020-2025 | Ilumya, Winlevi, Absorica Ld |
| Janssen Scientific Affairs, LLC | $125.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $122.06 | 2024-2025 | Sotyktu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.40 | 2022-2025 | Spevigo |
| Leo Pharma INC. | $96.82 | 2023-2025 | Adbry |
| Incyte Corporation | $92.31 | 2022-2024 | Opzelura |
| Novartis Pharmaceuticals Corporation | $90.41 | 2024-2025 | |
| Genzyme Corporation | $41.32 | 2023-2024 | |
| Amgen INC. | $34.69 | 2020-2024 | Otezla |
| Ucb, INC. | $34.30 | 2022-2025 | Bimzelx |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $22.21 | 2023 | Xolair |
| Vyne Pharmaceuticals INC. | $21.76 | 2021 | |
| Medline Industries LP | $21.05 | 2019 | |
| Pfizer INC. | $16.99 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Killian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.